Northern Capital Management (Wisconsin)’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $3.42M | Buy |
47,625
+1,485
| +3% | +$107K | 0.92% | 38 |
|
|
2018
Q3 | $4.42M | Sell |
46,140
-995
| -2% | -$95.4K | 1.02% | 36 |
|
|
2018
Q2 | $4.49M | Sell |
47,135
-1,195
| -2% | -$114K | 1.09% | 30 |
|
|
2018
Q1 | $4.24M | Sell |
48,330
-1,230
| -2% | -$108K | 1.09% | 29 |
|
|
2017
Q4 | $4.21M | Buy |
49,560
+2,275
| +5% | +$193K | 1.08% | 24 |
|
|
2017
Q3 | $4.09M | Sell |
47,285
-1,105
| -2% | -$95.6K | 1.26% | 21 |
|
|
2017
Q2 | $3.74M | Buy |
48,390
+1,095
| +2% | +$84.5K | 1.39% | 18 |
|
|
2017
Q1 | $3.28M | Buy |
47,295
+2,155
| +5% | +$149K | 1.31% | 23 |
|
|
2016
Q4 | $2.67M | Buy |
45,140
+875
| +2% | +$51.8K | 1.12% | 33 |
|
|
2016
Q3 | $2.93M | Sell |
44,265
-115
| -0.3% | -$7.62K | 1.32% | 24 |
|
|
2016
Q2 | $2.4M | Buy |
44,380
+3,880
| +10% | +$210K | 1.07% | 36 |
|
|
2016
Q1 | $2.09M | Buy |
40,500
+37,275
| +1,156% | +$1.93M | 0.93% | 43 |
|
|
2015
Q4 | $226K | Hold |
3,225
| – | – | 0.1% | 138 |
|
|
2015
Q3 | $201K | Hold |
3,225
| – | – | 0.09% | 142 |
|
|
2015
Q2 | $271K | Sell |
3,225
-90
| -3% | -$7.56K | 0.13% | 122 |
|
|
2015
Q1 | $249K | Hold |
3,315
| – | – | 0.12% | 123 |
|
|
2014
Q4 | $206K | Buy |
+3,315
| New | +$206K | 0.1% | 136 |
|
|
2013
Q3 | – | Sell |
-6,510
| Closed | -$226K | – | 144 |
|
|
2013
Q2 | $226K | Buy |
+6,510
| New | +$226K | 0.14% | 109 |
|